Abstract

Arginine methylation of histones plays a critical role in regulating gene expression. The writers (methyltransferases) and readers of methylarginine marks are well-known, but the erasers–arginine demethylases–remain mysterious. Here we identify Myc-induced nuclear antigen 53 (Mina53), a jumonji C domain containing protein, as an arginine demethylase for removing asymmetric di-methylation at arginine 3 of histone H4 (H4R3me2a). Using a photoaffinity capture method, we first identify Mina53 as an interactor of H4R3me2a. Biochemical assays in vitro and in cells characterize the arginine demethylation activity of Mina53. Molecular dynamics simulations provide further atomic-level evidence that Mina53 acts on H4R3me2a. In a transgenic mouse model, specific Mina53 deletion in neural stem/progenitor cells prevents H4R3me2a demethylation at distinct genes clusters, dysregulating genes important for neural stem/progenitor cell proliferation and differentiation, and consequently impairing the cognitive function of mice. Collectively, we identify Mina53 as a bona fide H4R3me2a eraser, expanding the understanding of epigenetic gene regulation.

Mina53 is identified as the enzyme responsible for removing histone 4 arginine 3 asymmetric dimethylation and is important to regulate gene expressions critical for neural stem/progenitor cell proliferation.

Details

Title
Mina53 demethylates histone H4 arginine 3 asymmetric dimethylation to regulate neural stem/progenitor cell identity
Author
Zhou, Lixiao 1 ; Zhao, Xingsen 2   VIAFID ORCID Logo  ; Sun, Jie 1 ; Zou, Kun 3 ; Huang, Xiaoli 4 ; Yu, Liyang 1 ; Wu, Mingxuan 3   VIAFID ORCID Logo  ; Wang, Yong 1   VIAFID ORCID Logo  ; Li, Xuekun 5   VIAFID ORCID Logo  ; Yi, Wen 6   VIAFID ORCID Logo 

 Zhejiang University, Departments of Biochemistry and Biophysics, College of Life Sciences, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Xianghu Laboratory, Institute of Biotechnology, Hangzhou, China (GRID:grid.488186.b) (ISNI:0000 0004 6066 2524) 
 Westlake University, Department of Chemistry, School of Science, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315) 
 Zhejiang University, The Children’s Hospital, National Clinical Research Center for Children Health, The Institute of Translational Medicine, School of Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Zhejiang University, The Children’s Hospital, National Clinical Research Center for Children Health, The Institute of Translational Medicine, School of Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University, Cancer Center, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Zhejiang University, Departments of Biochemistry and Biophysics, College of Life Sciences, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University, Cancer Center, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
Pages
10227
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3132705764
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.